Quinalizarin, a specific CK2 inhibitor, reduces cell viability and suppresses migration and accelerates apoptosis in different human lung cancer cell lines. (Q53221250)
Jump to navigation
Jump to search
scientific article published in December 2015
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Quinalizarin, a specific CK2 inhibitor, reduces cell viability and suppresses migration and accelerates apoptosis in different human lung cancer cell lines. |
scientific article published in December 2015 |
Statements
Quinalizarin, a specific CK2 inhibitor, reduces cell viability and suppresses migration and accelerates apoptosis in different human lung cancer cell lines. (English)
Y Zhou
K Li
S Zhang
Q Li
Z Li
F Zhou
X Dong
L Liu
G Wu
R Meng
1 December 2015
52 Suppl 2
e119-24